Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain CLVS message board posts where the ticker symbol CLVS has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest CLVS SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-20-009259 Size: 9 KB
2020-03-23
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-20-009258 Size: 9 KB
2020-03-23
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000834237-20-009179 (34 Act)  Size: 12 KB
2020-03-09 005-86488
20698259
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-20-007186 Size: 14 KB
2020-03-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-20-007185 Size: 15 KB
2020-03-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-20-007184 Size: 14 KB
2020-03-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-20-007183 Size: 14 KB
2020-03-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-20-006483 Size: 9 KB
2020-03-02
10-K  Documents   Interactive Data Annual report [Section 13 and 15(d), not S-K Item 405]
Acc-no: 0001558370-20-001500 (34 Act)  Size: 14 MB
2020-02-26 001-35347
20657299
8-K  Documents   Interactive Data Current report, items 2.02 and 9.01
Acc-no: 0001193125-20-046720 (34 Act)  Size: 238 KB
2020-02-24 001-35347
20645620
More CLVS SEC Filings


Related news from
Fri, 03 Apr 2020
21:50:09 +0000
Clovis Oncology (CLVS) Gains As Market Dips: What You Should Know
Clovis Oncology (CLVS) closed the most recent trading day at $6.10, moving +0.49% from the previous trading session.
Wed, 25 Mar 2020
15:30:03 +0000
Why Is Clovis (CLVS) Down 41.6% Since Last Earnings Report?
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Fri, 20 Mar 2020
13:36:01 +0000
Is the Options Market Predicting a Spike in Clovis Oncology (CLVS) Stock?
Investors need to pay close attention to Clovis Oncology (CLVS) stock based on the movements in the options market lately.
Thu, 19 Mar 2020
21:50:09 +0000
Clovis Oncology (CLVS) Gains But Lags Market: What You Should Know
Clovis Oncology (CLVS) closed the most recent trading day at $4.50, moving +0.45% from the previous trading session.
Tue, 03 Mar 2020
13:30:00 +0000
Clovis Oncology to Present at the Barclays Global Healthcare Conference
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the Barclays Global Healthcare Conference on Tuesday, March 10, 2020 at 11:15 a.m. Eastern time. The conference will be held at the Loews Miami Beach Hotel in Miami.
Mon, 02 Mar 2020
09:00:00 +0000
Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Spain
Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Spain
Thu, 27 Feb 2020
12:24:07 +0000
Edited Transcript of CLVS earnings conference call or presentation 24-Feb-20 9:30pm GMT
Q4 2019 Clovis Oncology Inc Earnings Call
Wed, 26 Feb 2020
14:02:35 +0000
Here's What Analysts Are Forecasting For Clovis Oncology, Inc. After Its Full-Year Results
There's been a major selloff in Clovis Oncology, Inc. (NASDAQ:CLVS) shares in the week since it released its annual...
Tue, 25 Feb 2020
15:12:03 +0000
Clovis (CLVS) Q4 Loss Wider Than Expected, Revenues Beat
Clovis (CLVS) reports mixed fourth-quarter 2019 results. The company's sole marketed drug, Rubraca, drives revenues. Shares down.
Mon, 24 Feb 2020
23:15:11 +0000
Clovis Oncology (CLVS) Reports Q4 Loss, Tops Revenue Estimates
Clovis (CLVS) delivered earnings and revenue surprises of -12.42% and 1.35%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Mon, 24 Feb 2020
21:05:00 +0000
Clovis Oncology Announces 2019 Operating Results
Clovis Oncology Announces 2019 Operating Results
Fri, 21 Feb 2020
16:30:04 +0000
Is Clovis Oncology (CLVS) Outperforming Other Medical Stocks This Year?
Is (CLVS) Outperforming Other Medical Stocks This Year?
Wed, 19 Feb 2020
15:13:03 +0000
What's in Store for Aimmune (AIMT) This Earnings Season?
Aimmune (AIMT) is likely to provide an update on Palforzia's launch plans during Q4 investors' call. The drug gets an approval in January 2020 for the treatment of peanut allergy.
Wed, 19 Feb 2020
14:39:02 +0000
Is a Beat in the Cards for Clovis' (CLVS) Earnings in Q4?
Clovis' (CLVS) sole marketed drug, Rubraca, is likely to have driven revenues in the fourth quarter.
Wed, 19 Feb 2020
13:39:01 +0000
Implied Volatility Surging for Clovis Oncology (CLVS) Stock Options
Investors need to pay close attention to Clovis Oncology (CLVS) stock based on the movements in the options market lately.
Thu, 13 Feb 2020
13:30:00 +0000
Clovis Oncology to Announce Fourth Quarter/Full Year 2019 Financial Results and Host Webcast Conference Call on February 24
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter and full year 2019 financial results on Monday, February 24, 2020, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the company’s results in greater detail.
Tue, 11 Feb 2020
21:05:00 +0000
Clovis Oncology to Present at the 9th Annual SVB Leerink Healthcare Conference
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its Chief Executive Officer and President, Patrick J. Mahaffy, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020 at 10:30 a.m. Eastern Standard Time. The conference will be held at the Lotte New York Palace in New York City.
Thu, 06 Feb 2020
20:34:06 +0000
4 Stocks Looking Higher During Earnings Season
Clovis Oncology, Inc. (NASDAQ: CLVS) popped 90 cents, or more than 10%, to $9.73 on 11.7 million shares Wednesday on no news. 3D Systems Corporation (NYSE: DDD) climbed 63 cents, or 5.3%, to $12.34 on 2.9 million shares Wednesday. Wednesday's move broke the stock out of a month-long wedge formation, and next resistance for the stock, which has nearly doubled in 5 months, is at $14.25.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is a great group of very smart, sophisticated investors. We have several professionals on board managing millions of dollars, and "average Joe" investors that beat the pants off of Wall Street professionals year in and year out. ValueForum will expose you to a wealth of ideas and sectors, and keep you ahead of the curve." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2020, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards